Lexaria Bioscience
Price & Volume
Stats
See more52W Range | $1.38-$6.85 |
Market Cap | $25.1M |
Shares Short | 610,356 |
Financials
See moreRevenue (12 Mos) | $496,923 |
Revenue Growth (YoY) | 21.6% |
Gross Profit (12 Mos) | $494,203 |
Diluted EPS | -$0.50 |
News
See moreYahoo Finance • last year
Lexaria Bioscience Corp. (NASDAQ: LEXX) Evaluating Proprietary Drug-Delivery Platform for Improved Efficacy of GLP-1 Drugs
Yahoo Finance • 3 years ago
Lexaria Bioscience Corp. (NASDAQ: LEXX) Focused on Filling Need for Hypertension Treatment Solution
Yahoo Finance • 3 years ago
Lexaria Bioscience Corp. (NASDAQ: LEXX) Stands as Global Leader in Delivery Tech Space
Yahoo Finance • 3 years ago
Lexaria Bioscience Corp. (NASDAQ: LEXX) Offers Breakthrough Delivery Tech in Hot Nicotine Space
About
CEO | Mr. Richard C. Christopher |
Address | 740 McCurdy Road, Kelowna, BC, Canada, V1X 2P7 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 7 |
